Legal Opinion
Finkelstein v. Hemispherx Biopharma, Inc.
District of Columbia Court of Appeals
Decided June 14, 2001No. 99-CV-338PublishedCited by 51 opinions
1Opinion of the Court
GLICKMAN, Associate Judge:
Appellee Hemispherx Biopharma, Inc. (“Hemispherx”) sued appellants Donald J. Enright and his law firm Finkelstein, Thompson & Loughran, claiming that En-right slandered it when he solicited one of Hemispherx’s shareholders as a client in order to bring a potential shareholders’ derivative or class action lawsuit against Hemispherx. Invoking the absolute privilege recognized in this jurisdiction for defamatory statements by an attorney that are preliminary to a proposed judicial proceeding, appellants moved to dismiss the defamation count of the complaint. The trial…
2Cases cited25 opinions
- Mitchell v. ForsythSupreme Court of the United States · 1985
- Chambers v. Nasco, Inc.Supreme Court of the United States · 1991
- Johnson v. JonesSupreme Court of the United States · 1995
- Digital Equipment Corp. v. Desktop Direct, Inc.Supreme Court of the United States · 1994
- Surowitz v. Hilton Hotels Corp.Supreme Court of the United States · 1966
20 more not listed; retrieve them via the Exa API.
3Cited by51 opinions
- Dolly Kyle Browning and Direct Outstanding Creations Corporation v. William Jefferson ClintonCourt of Appeals for the D.C. Circuit · 2002
- Oparaugo v. WattsDistrict of Columbia Court of Appeals · 2005
- Messina, Karyn v. Krakower, DanielCourt of Appeals for the D.C. Circuit · 2006
- COMPETITIVE ENTERPRISE INSTITUTE AND RAND SIMBERG v. MICHAEL E. MANN, NATIONAL REVIEW, INC. v. MICHAEL E. MANNDistrict of Columbia Court of Appeals · 2016
- Heard v. JohnsonDistrict of Columbia Court of Appeals · 2002
46 more not listed; retrieve them via the Exa API.